Vivos (RDGL) Operating Leases (2025)
Vivos (RDGL) reported Operating Leases of $88851.0 for Q4 2025.
Vivos (RDGL) Operating Leases (2025) Analysis & Trends
Vivos (RDGL) has 1 years of Operating Leases data on file, last reported at $88851.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases changed N/A year-over-year to $88851.0; the trailing twelve-month figure through Dec 2025 stood at $88851.0 (changed N/A YoY), and the FY2025 full-year result was $88851.0, changed N/A from the prior year.
- Operating Leases held at $88851.0 in Q4 2025.
- In the past five years, Operating Leases ranged from a high of $88851.0 in Q4 2025 to a low of $88851.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,851.00 |